<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL), anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-beta 2-GPI) and anti-oxidized-<z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) antibodies are <z:hpo ids='HP_0000001'>all</z:hpo> implicated in the pathogenesis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate whether different autoantibodies or combinations thereof produced distinct effects related to their antigenic specificities, we examined the frequencies of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS)-related features in the presence of different antibodies [aPL, beta 2-GPI, anti-oxidized <z:chebi fb="2" ids="39026">low density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>)] in 125 patients with APS </plain></SENT>
<SENT sid="2" pm="."><plain>Median follow-up was 72 months: 58 patients were diagnosed as primary APS and 67 as APS plus <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="3" pm="."><plain>Anticardiolipin antibodies (aCL), anti-beta 2-GPI and anti-oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi> antibodies were determined by ELISA; <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) by standard coagulometric methods </plain></SENT>
<SENT sid="4" pm="."><plain>Univariate analysis showed that patients positive for anti-beta 2-GPI had a higher risk of recurrent thrombotic events (OR = 3.64, 95% CI, p = 0.01) and pregnancy loss (OR = 2.99, 95% CI, p = 0.004) </plain></SENT>
<SENT sid="5" pm="."><plain>Patients positive for anti-oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi> antibodies had a 2.24-fold increase in the risk of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> (2.24, 95% CI, p = 0.03) and lower risk of <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (OR = 0.41 95% CI, p = 0.04) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients positive for aCL antibodies had a higher risk of pregnancy loss (OR = 4.62 95% CI, p = 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>When these data were tested by multivariate logistic regression, the association between anti-beta 2-GPI and pregnancy loss and the negative association between anti-oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi> antibodies and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> disappeared </plain></SENT>
</text></document>